MTHFD1L and colorectal carcinoma: K-M Survival analysis showed that the five-year survival rate of CRC patients with high MTHFD1L expression level was significantly dropped than those with low MTHFD1L expression level (61.2±4.5% vs. 93.1±3.3%, P<0.01, Figure 2D).